Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.390
-0.040 (-1.65%)
At close: Jul 24, 2026, 4:00 PM EDT
2.385
-0.005 (-0.21%)
After-hours: Jul 24, 2026, 7:34 PM EDT

Organogenesis Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
514.7564.17482.04433.14450.89467.36
Revenue Growth
12.20%17.04%11.29%-3.94%-3.52%38.15%
Gross Profit
375.13426.65366.3326.66345.87353.16
Operating Income
2.5544.69-1.2812.5322.372.22
Net Income
-18.7120.02-0.944.9515.5394.2
Earnings Per Share
-0.190.15-0.010.040.120.70
EPS Growth
----66.67%-82.86%366.67%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
92.194.33136.15104.34103.29114.53
Total Debt
99.4899.986.41119.35123.79133.74
Net Cash (Debt)
-7.38-5.5749.74-15.01-20.5-19.21
Net Cash Growth
------
Net Cash Per Share
-0.06-0.040.38-0.11-0.15-0.14

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
51.4410.389.163.1424.8661.98
Capital Expenditures
-13.67-14.15-10.03-24.36-33.9-31.22
Free Cash Flow
37.77-3.77-0.87-21.23-9.0430.76
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
72.88%75.62%75.99%75.42%76.71%75.56%
Operating Margin
0.50%7.92%-0.27%2.89%4.95%15.45%
Pretax Margin
0.83%8.33%-0.58%2.40%4.50%13.50%
Profit Margin
0.53%6.56%0.18%1.14%3.44%20.16%
FCF Margin
7.34%-0.67%-0.18%-4.90%-2.00%6.58%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-34.53-102.2522.4213.20
Forward PE
-24.6758.18136.3311.9623.39
P/FCF Ratio
18.00----38.66
PS Ratio
0.601.170.831.240.782.54